In addition, elevated osteonectin levels in primary prostate cancer was associated with the subsequent development of metastasis [22], indicating that prostate cancer cell metastasis to the bone is mediated in part by the osteonectin-mediated promotion of cancer cell migration, protease activity, and invasion. This evidence concerns the gene SPARC and prostate carcinoma.